Memantina [INN-Spanish]

Memantina [INN-Spanish] Brand names, Memantina [INN-Spanish] Analogs

Memantina [INN-Spanish] Brand Names Mixture

No information avaliable

Memantina [INN-Spanish] Chemical_Formula

C₁₂H₂₁N

Memantina [INN-Spanish] RX_link

http://www.rxlist.com/cgi/generic3/namenda.htm

Memantina [INN-Spanish] fda sheet

Memantina_[INN-Spanish] FDA

Memantina [INN-Spanish] msds (material safety sheet)

Memantina_[INN-Spanish] MSDS

Memantina [INN-Spanish] Synthesis Reference

No information avaliable

Memantina [INN-Spanish] Molecular Weight

179.302 g/mol

Memantina [INN-Spanish] Melting Point

258 ^oC (HCl salt)

Memantina [INN-Spanish] H₂O Solubility

35 mg/mL (HCl salt), 0.9 mg/mL for free base

Memantina [INN-Spanish] State

Solid

Memantina [INN-Spanish] LogP

2.197

Memantina [INN-Spanish] Dosage Forms

Tablet

Memantina [INN-Spanish] Indication

For the treatment of moderate to severe dementia of the Alzheimer's type.

Memantina [INN-Spanish] Pharmacology

Memantine, an amantadine derivative, is an NMDA receptor antagonist used in the treatment of Alzheimer's disease. It differs from traditional agents used in Alzheimer's disease by acting on glutamatergic neurotransmission, rather than cholinergic. There is some evidence that dysfunction of glutamatergic neurotransmission, manifested as neuronal excitotoxicity, is involved in the aetiology of Alzheimer's disease (Cacabelos et al., 1999). As such, targeting the glutamatergic system, specifically NMDA receptors, was a novel approach to treatment in view of the limited efficacy of existing drugs targeting the cholinergic system. A systematic review of randomised controlled trials found that memantine has a positive effect on cognition, mood, behaviour, and the ability to perform daily activities. There is no evidence that memantine prevents or slows neurodegeneration in patients with Alzheimer's disease.

Memantina [INN-Spanish] Absorption

Well absorbed orally with a bioavailability of approximately 100%. Peak plasma concentrations are reached in 3-7 hours. Food has no effect on absorption.

Memantina [INN-Spanish] side effects and Toxicity

Side effects include pain, abnormal crying, leg pain, fever, increased apetite. Adverse drug reactions include: dizziness, confusion, headache, hallucinations, tiredness. Less common side effects include: vomiting, anxiety, hypertonia, cystitis, and increased libido. Doses of up to 400 mg have been tolerated.

Memantina [INN-Spanish] Patient Information

Information for Patients and Caregivers: Caregivers should be instructed in the recommended administration (twice per day for doses above 5 mg) and dose escalation (minimum interval of one week between dose increases).

Memantina [INN-Spanish] Organisms Affected

Humans and other mammals